Weekly schedule of vinorelbine in pretreated breast cancer patients


Purpose: In this phase II study, we explored tolerability and activity of vinorelbine administered according to a dose-dense weekly schedule with hematopoietic growth factor support in pretreated, advanced breast cancer patients. Patients and Methods: From January 1994 to March 1996, 40 patients with metastatic breast cancer, pretreated with at least one… (More)
DOI: 10.1023/A:1006390700480


5 Figures and Tables